Journal of Korean Association of Cancer prevention 2004; 9(3): 180-187
Published online September 30, 2004
© Korean Society of Cancer Prevention
Young-Joo Oh and Mi-Kyung Sung1
Epidemiological studies have indicated that whole-grain intake has a protective effect against cancer. Our previous report showed that brown rice extracts have cytotoxic effects on hormone-dependent and -independent breast cancer cells. The present study was carried out to investigate anticarcinogenic potential of dietary brown rice in experimental rat mammary carcinogenesis. At 52 days of age, female Sprague-Dawley rats were given a single dose of 5mg 7,12-dimethylbenz-(a)anthracene (DMBA) by an intragastric administration. Animals were subdivided into 4 groups with 10 animals each and fed experimental diets for 23 weeks. Diets were composed as follows: AIN-76 control diet (CT), AIN-76 control diet50% brown rice (CTBR), AIN-76 control diet with 20% corn oil (HF), AIN-76 control diet with 20% corn oil 50% brown rice (HFBR). Beginning 8 wks after DMBA administration, all rats were palpated weekly for mammary tumors, and the tumor incidence, location, and size were recorded for fuerhwe 15 wks. Results indicted that brown rice tended to decrease tumor size in rats fed either control diet or high fat diet. Breast tumor incidence, 20% in CTBR, 22% in CT, 33% in HFBR, 44% in HF. HF-fed animals had the shortest latency period and brown rice diet delayed the period, although no statistical significance was found. It is concluded that brown rice-based diet may suppress the formation of mammary tumors and tumor growth, however, further studies are required to elucidate possible mechanisms and responsible compound(s).
Keywords: Whole grain, Brown rice, Breast cancer, DMBA
Dessiet Oma, Maria Teklemariam, Daniel Seifu, Zelalem Desalegn, Endale Anberbir, Tamrat Abebe, Solomon Mequannent, Solomon Tebeje, Wajana Lako Labisso
J Cancer Prev 2023; 28(2): 64-74 https://doi.org/10.15430/JCP.2023.28.2.64Eun-Ryeong Hahm, Sivapar V. Mathan, Rana P. Singh, Shivendra V. Singh
J Cancer Prev 2022; 27(2): 101-111 https://doi.org/10.15430/JCP.2022.27.2.101Jinyoung Suh, Do-Hee Kim, Su-Jung Kim, Nam-Chul Cho, Yeon-Hwa Lee, Jeong-Hoon Jang, Young-Joon Surh
J Cancer Prev 2022; 27(1): 68-76 https://doi.org/10.15430/JCP.2022.27.1.68